According to our latest research, the global bladder cancer therapeutics and diagnostics market size reached USD 6.8 billion in 2024, with a robust compound annual growth rate (CAGR) of 5.7% projected through the forecast period. By 2033, the market is anticipated to achieve a value of USD 11.4 billion. The market's expansion is primarily driven by the growing prevalence of bladder cancer worldwide, increasing adoption of advanced diagnostic technologies, and a strong focus on personalized medicine. As per the latest research, the integration of innovative therapeutics and diagnostics is playing a pivotal role in improving patient outcomes, thus accelerating the overall market growth. https://growthmarketreports.com/report/bladder-cancer-therapeutics-and-diagnostics-market-global-industry-analysis